Table 4.
Results of multivariate analysis
| Logistic regression for HIV VL ≥10,000 copies/mL | Linear regression for log10 HIV VL | |||
|---|---|---|---|---|
| Adjusted OR (95% CI) |
P-value | Parameter estimates (95% CI) |
P-value | |
| WHO clinical stage | ||||
| Stage 1 | Reference | Reference | ||
| Stage 2 | 1.5 (0.93–2.42) | 0.0962 | 0.06 (−0.11–0.24) | 0.4913 |
| Gender/MSM | ||||
| MSM | 3.08 (1.91–4.95) | <0.0001 | 0.38 (0.22–0.55) | <0.0001 |
| Male (Non-MSM) | 1.98 (1.4–2.8) | 0.0001 | 0.26 (0.12–0.39) | 0.0002 |
| Female | Reference | Reference | ||
| Age | ||||
| 18–25 | 1.1 (0.69–1.77) | 0.688 | 0.06 (-0.12–0.24) | 0.5163 |
| 26–35 | 1 (0.72–1.38) | 0.9861 | -0.04 (-0.17–0.09) | 0.5386 |
| 36–64 | Reference | Reference | ||
| Current CD4 cell count (cells/mm3) | ||||
| 351–500 | 1.46 (1.09–1.94) | 0.0106 | 0.24 (0.13–0.35) | <0.0001 |
| >500 | Reference | Reference | ||
| Recently diagnosed HIV infection | ||||
| Yes | 1.82 (1.2–2.78) | 0.0053 | 0.21 (0.06–0.37) | 0.0051 |
| No | Reference | Reference | ||
| URI/viral symptoms | ||||
| Yes | 1.4 (1.02–1.92) | 0.0375 | 0.11 (-0.02–0.23) | 0.0863 |
| No | Reference | Reference | ||
| HBsAg | ||||
| Positive | 1.64 (1.02–2.65) | 0.0414 | 0.19 (0.01–0.36) | 0.0348 |
| Negative | Reference | Reference | ||
| Anti-HCV | ||||
| Positive | 0.64 (0.45–0.91) | 0.0132 | -0.15 (-0.28–-0.01) | 0.0362 |
| Negative | Reference | Reference | ||